A noncanonical, GSK3-independent pathway controls postprandial hepatic glycogen deposition

Cell Metabolism

Volumn 18, Issue 1, 2013, Pages 99-105

  Wan, Min ^a   Leavens, Karla F ^a   Hunter, Roger W ^b,c   Koren, Shlomit ^a   Von Wilamowitz Moellendorff, Alexander ^c   Lu, Mingjian ^a   Satapati, Santhosh ^d   Chu, Qingwei ^a   Sakamoto, Kei ^b,c   Burgess, Shawn C ^d   Birnbaum, Morris J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b EPFL   (Switzerland)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE; GLYCOGEN; INSULIN; PROTEIN KINASE B BETA;

ANIMAL EXPERIMENT; ARTICLE; CARBOHYDRATE SYNTHESIS; GLUCONEOGENESIS; GLYCOGEN LIVER LEVEL; GLYCOGEN METABOLISM; GLYCOGEN SYNTHESIS; GLYCOGENOLYSIS; HYPERINSULINEMIA; LIVER METABOLISM; MOUSE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE-6-PHOSPHATE; GLYCOGEN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGENOLYSIS; HYPERINSULINISM; INSULIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POSTPRANDIAL PERIOD; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

MUS;

EID: 84879857725     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.06.001     Document Type: Article

References (27)

1. J.E. Ayala, D.P. Bracy, O.P. McGuinness, and D.H. Wasserman Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse Diabetes 55 2006 390 397
2. M. Bouskila, M.F. Hirshman, J. Jensen, L.J. Goodyear, and K. Sakamoto Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle Am. J. Physiol. Endocrinol. Metab. 294 2008 E28 E35
3. M. Bouskila, R.W. Hunter, A.F. Ibrahim, L. Delattre, M. Peggie, J.A. van Diepen, P.J. Voshol, J. Jensen, and K. Sakamoto Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle Cell Metab. 12 2010 456 466
4. S.C. Burgess, N. Hausler, M. Merritt, F.M. Jeffrey, C. Storey, A. Milde, S. Koshy, J. Lindner, M.A. Magnuson, C.R. Malloy, and A.D. Sherry Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase J. Biol. Chem. 279 2004 48941 48949
5. H. Cho, J. Mu, J.K. Kim, J.L. Thorvaldsen, Q. Chu, E.B. Crenshaw 3rd, K.H. Kaestner, M.S. Bartolomei, G.I. Shulman, and M.J. Birnbaum Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta) Science 292 2001 1728 1731
6. B. Christ, I. Probst, and K. Jungermann Antagonistic regulation of the glucose/glucose 6-phosphate cycle by insulin and glucagon in cultured hepatocytes Biochem. J. 238 1986 185 191
7. P. Cohen The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction Philos. Trans. R. Soc. Lond. B Biol. Sci. 354 1999 485 495
8. D.A. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, and B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789
9. M. David, W.A. Petit, M.R. Laughlin, R.G. Shulman, J.E. King, and E.J. Barrett Simultaneous synthesis and degradation of rat liver glycogen. An in vivo nuclear magnetic resonance spectroscopic study J. Clin. Invest. 86 1990 612 617
10. D.S. Edgerton, S. Cardin, M. Emshwiller, D. Neal, V. Chandramouli, W.C. Schumann, B.R. Landau, L. Rossetti, and A.D. Cherrington Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism Diabetes 50 2001 1872 1882
11. L. Guignot, and G. Mithieux Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rat Am. J. Physiol. 277 1999 E984 E989
12. S. Halimi, F. Assimacopoulos-Jeannet, J. Terrettaz, and B. Jeanrenaud Differential effect of steady-state hyperinsulinaemia and hyperglycaemia on hepatic glycogenolysis and glycolysis in rats Diabetologia 30 1987 268 272
13. K. Inoki, H. Ouyang, T. Zhu, C. Lindvall, Y. Wang, X. Zhang, Q. Yang, C. Bennett, Y. Harada, and K. Stankunas TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth Cell 126 2006 955 968
14. M. Krssak, A. Brehm, E. Bernroider, C. Anderwald, P. Nowotny, C. Dalla Man, C. Cobelli, G.W. Cline, G.I. Shulman, W. Waldhäusl, and M. Roden Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes Diabetes 53 2004 3048 3056
15. K.F. Leavens, R.M. Easton, G.I. Shulman, S.F. Previs, and M.J. Birnbaum Akt2 is required for hepatic lipid accumulation in models of insulin resistance Cell Metab. 10 2009 405 418
16. H.V. Lin, and D. Accili Hormonal regulation of hepatic glucose production in health and disease Cell Metab. 14 2011 9 19
17. M. Lu, M. Wan, K.F. Leavens, Q. Chu, B.R. Monks, S. Fernandez, R.S. Ahima, K. Ueki, C.R. Kahn, and M.J. Birnbaum Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1 Nat. Med. 18 2012 388 395
18. M.L. Massa, J.J. Gagliardino, and F. Francini Liver glucokinase: An overview on the regulatory mechanisms of its activity IUBMB Life 63 2011 1 6
19. E.J. McManus, K. Sakamoto, L.J. Armit, L. Ronaldson, N. Shpiro, R. Marquez, and D.R. Alessi Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis EMBO J. 24 2005 1571 1583
20. C.B. Newgard, L.J. Hirsch, D.W. Foster, and J.D. McGarry Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat. A direct or an indirect pathway? J. Biol. Chem. 258 1983 8046 8052
21. K.F. Petersen, D. Laurent, D.L. Rothman, G.W. Cline, and G.I. Shulman Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans J. Clin. Invest. 101 1998 1203 1209
22. P.J. Roach, A.A. Depaoli-Roach, T.D. Hurley, and V.S. Tagliabracci Glycogen and its metabolism: some new developments and old themes Biochem. J. 441 2012 763 787
23. D.L. Rothman, I. Magnusson, L.D. Katz, R.G. Shulman, and G.I. Shulman Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR Science 254 1991 573 576
24. G.I. Shulman, D.L. Rothman, D. Smith, C.M. Johnson, J.B. Blair, R.G. Shulman, and R.A. DeFronzo Mechanism of liver glycogen repletion in vivo by nuclear magnetic resonance spectroscopy J. Clin. Invest. 76 1985 1229 1236
25. N. Somaiah, and G.R. Simon Molecular targeted agents and biologic therapies for lung cancer J. Thorac. Oncol. 6 11, Suppl 4 2011 S1758 S1785
26. R. Taylor, I. Magnusson, D.L. Rothman, G.W. Cline, A. Caumo, C. Cobelli, and G.I. Shulman Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects J. Clin. Invest. 97 1996 126 132
27. M. Wan, K.F. Leavens, D. Saleh, R.M. Easton, D.A. Guertin, T.R. Peterson, K.H. Kaestner, D.M. Sabatini, and M.J. Birnbaum Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c Cell Metab. 14 2011 516 527